[go: up one dir, main page]

AU2001258442A1 - Drug delivery device, especially for the delivery of levonorgestrel - Google Patents

Drug delivery device, especially for the delivery of levonorgestrel

Info

Publication number
AU2001258442A1
AU2001258442A1 AU2001258442A AU5844201A AU2001258442A1 AU 2001258442 A1 AU2001258442 A1 AU 2001258442A1 AU 2001258442 A AU2001258442 A AU 2001258442A AU 5844201 A AU5844201 A AU 5844201A AU 2001258442 A1 AU2001258442 A1 AU 2001258442A1
Authority
AU
Australia
Prior art keywords
levonorgestrel
delivery
delivery device
drug delivery
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258442A
Inventor
Juha Ala-Sorvari
Harri Jukarainen
Matti Lehtinen
Tommi Markkula
Jarkko Ruohonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of AU2001258442A1 publication Critical patent/AU2001258442A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001258442A 2000-05-10 2001-04-27 Drug delivery device, especially for the delivery of levonorgestrel Abandoned AU2001258442A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56802800A 2000-05-10 2000-05-10
US09568028 2000-05-10
PCT/FI2001/000406 WO2001085132A1 (en) 2000-05-10 2001-04-27 Drug delivery device, especially for the delivery of levonorgestrel

Publications (1)

Publication Number Publication Date
AU2001258442A1 true AU2001258442A1 (en) 2001-11-20

Family

ID=24269633

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258442A Abandoned AU2001258442A1 (en) 2000-05-10 2001-04-27 Drug delivery device, especially for the delivery of levonorgestrel

Country Status (2)

Country Link
AU (1) AU2001258442A1 (en)
WO (1) WO2001085132A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2009029958A2 (en) * 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
AU2011270997A1 (en) * 2010-06-22 2013-01-10 Teva Women's Health, Inc. Intravaginal devices comprising anticholinergic agents, and methods of making thereof
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
AR089765A1 (en) 2012-01-23 2014-09-17 Bayer Oy A SYSTEM FOR THE SUPPLY OF A PHARMACO
USD718435S1 (en) 2012-05-30 2014-11-25 Medicines360 Intrauterine insertion device
CN103041455B (en) * 2013-01-10 2014-07-23 扬州大学临床医学院 Biodegradable nano drug-supported slow-release intrauterine device and preparation method thereof
CN106546706B (en) * 2015-09-21 2020-03-17 上海复旦张江生物医药股份有限公司 In-vitro release test method for liposome drug prepared by pH gradient active drug loading method
CN106546705B (en) * 2015-09-21 2020-03-17 上海复旦张江生物医药股份有限公司 Test method for in-vitro release of liposome drug

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use

Also Published As

Publication number Publication date
WO2001085132A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU2001264887A1 (en) Drug delivery device
AU2001273376A1 (en) Drug delivery device for animals
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
AU2001235009A1 (en) Drug delivery apparatus
AU2002246500A1 (en) Thermal vaporizing device for drug delivery
AU2001238386A1 (en) Medication delivery devices
AU2001261425A1 (en) Cases for medication delivery devices
AU4947100A (en) Drug delivery device
AU2997500A (en) Single dose delivery device
AU2002218250A1 (en) Medicament dispenser
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
AU2001272645A1 (en) Delivery device
AU2002223562A1 (en) Medicament dispenser
AU2002214006A1 (en) Drugs for diabetes
AU2002360717A1 (en) Controlled release dosage form having improved drug release properties
HUP0202666A3 (en) Drug delivery device, especially for the delivery of androgens
AU3837999A (en) Drug delivery device
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
AU2001270963A1 (en) Transdermal drug delivery system
AU2001224818A1 (en) Device for administering liquids
AU2002221099A1 (en) Combination drugs
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
AU2001270749A1 (en) Delivery device
AU2001232244A1 (en) Drug comprising combination